Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

ENDRA Life Sciences (NDRA) Leases (2019 - 2025)

ENDRA Life Sciences has reported Leases over the past 3 years, most recently at $643413.0 for Q4 2021.

  • Quarterly Leases rose 89.79% to $643413.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $643413.0 through Dec 2021, up 89.79% year-over-year, with the annual reading at $643413.0 for FY2021, 89.79% up from the prior year.
  • Leases was $643413.0 for Q4 2021 at ENDRA Life Sciences, down from $675822.0 in the prior quarter.
  • Over five years, Leases peaked at $707504.0 in Q2 2021 and troughed at $321563.0 in Q1 2021.
  • The 3-year median for Leases is $396961.5 (2019), against an average of $463050.5.
  • The largest YoY upside for Leases was 89.82% in 2021 against a maximum downside of 17.34% in 2021.
  • A 3-year view of Leases shows it stood at $404919.0 in 2019, then dropped by 16.28% to $339012.0 in 2020, then surged by 89.79% to $643413.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Leases are $643413.0 (Q4 2021), $675822.0 (Q3 2021), and $707504.0 (Q2 2021).